Logo image
Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants
Journal article   Peer reviewed

Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants

Nansi S Boghossian, Barbara T Do, Edward F Bell, John M Dagle, Jane E Brumbaugh, Barbara J Stoll, Betty R Vohr, Abhik Das, Seetha Shankaran, Pablo J Sanchez, …
Early human development, Vol.113, pp.10-17
10/2017
DOI: 10.1016/j.earlhumdev.2017.07.011
PMCID: PMC5654678
PMID: 28697406
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5654678View
Open Access

Abstract

Optimal management of the patent ductus arteriosus (PDA) in preterm infants remains controversial. Therefore, studies identifying infants who are most likely to benefit from PDA treatment are needed.
Indomethacin Premature infants Mortality Morbidity Ibuprofen

Details

Metrics

Logo image